Form 8-K - Current report:
SEC Accession No. 0000200406-21-000053
Filing Date
2021-07-21
Accepted
2021-07-21 08:00:52
Documents
18
Period of Report
2021-07-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20210721.htm   iXBRL 8-K 51025
2 EX-99.1 a2021q2exhibit991final.htm EX-99.1 57666
3 EX-99.2 a2021q2exhibit992final.htm EX-99.2 1185973
8 a2q21overallfinancialresula.jpg GRAPHIC 15553
9 a2q21regionalfinancialresua.jpg GRAPHIC 10518
10 a2q21salesbysegmentv2.jpg GRAPHIC 12563
  Complete submission text file 0000200406-21-000053.txt   1620352

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20210721.xsd EX-101.SCH 3542
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20210721_def.xml EX-101.DEF 17377
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20210721_lab.xml EX-101.LAB 35650
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20210721_pre.xml EX-101.PRE 18240
11 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20210721_htm.xml XML 20915
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0102
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 211102792
SIC: 2834 Pharmaceutical Preparations